129 related articles for article (PubMed ID: 8298608)
1. Colonic vasoactive intestinal polypeptide in ulcerative colitis.
Surrenti C; Renzi D; Garcea MR; Surrenti E; Salvadori G
J Physiol Paris; 1993; 87(5):307-11. PubMed ID: 8298608
[TBL] [Abstract][Full Text] [Related]
2. Substance P and vasoactive intestinal polypeptide but not calcitonin gene-related peptide concentrations are reduced in patients with moderate and severe ulcerative colitis.
Renzi D; Mantellini P; Calabrò A; Panerai C; Amorosi A; Paladini I; Salvadori G; Garcea MR; Surrenti C
Ital J Gastroenterol Hepatol; 1998 Feb; 30(1):62-70. PubMed ID: 9615269
[TBL] [Abstract][Full Text] [Related]
3. Colonic vasoactive intestinal polypeptide (VIP) in ulcerative colitis--a radioimmunoassay and immunohistochemical study.
Todorovic V; Janic B; Koko V; Micev M; Nikolic JA; Ratkovic M; Leposavic G; Jankovic T; Knezevic-Usaj S; Milicevic Z
Hepatogastroenterology; 1996; 43(9):483-8. PubMed ID: 8799381
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of intestinal mucosal mast cells expressing VPAC1 in close proximity to vasoactive intestinal polypeptide in inflammatory bowel disease and murine colitis.
Casado-Bedmar M; Heil SDS; Myrelid P; Söderholm JD; Keita ÅV
Neurogastroenterol Motil; 2019 Mar; 31(3):e13503. PubMed ID: 30407703
[TBL] [Abstract][Full Text] [Related]
5. Epithelial expression of vasoactive intestinal peptide in ulcerative colitis: down-regulation in markedly inflamed colon.
Jönsson M; Norrgård O; Forsgren S
Dig Dis Sci; 2012 Feb; 57(2):303-10. PubMed ID: 22143367
[TBL] [Abstract][Full Text] [Related]
6. Expression of mRNA for vasoactive intestinal peptide in normal human colon and during inflammation.
Schulte-Bockholt A; Fink JG; Meier DA; Otterson MF; Telford GL; Hopp K; Koch TR
Mol Cell Biochem; 1995 Jan; 142(1):1-7. PubMed ID: 7753037
[TBL] [Abstract][Full Text] [Related]
7. Decrease in binding for the neuropeptide VIP in response to marked inflammation of the mucosa in ulcerative colitis.
Jönsson M; Norrgård O; Hansson M; Forsgren S
Ann N Y Acad Sci; 2007 Jun; 1107():280-9. PubMed ID: 17804556
[TBL] [Abstract][Full Text] [Related]
8. Decreased colonic peptide histidine-methionine in idiopathic inflammatory bowel diseases.
Koch TR; Michener SR; Carney JA; Go VL
Dig Dis Sci; 1988 Apr; 33(4):423-8. PubMed ID: 3349889
[TBL] [Abstract][Full Text] [Related]
9. Role of free radical scavenging activity of vasoactive intestinal peptide in the attenuation of mitochondrial dysfunction to ameliorate dextran sulphate sodium-induced colitis in mice: Implications in ulcerative colitis.
Spoorthi BC; More SS; Gautham SA; Ghosh S; Saha I; Maiti AK
J Dig Dis; 2020 Dec; 21(12):711-723. PubMed ID: 33405317
[TBL] [Abstract][Full Text] [Related]
10. [Analysis of enteral nervous system in children with drug resistant ulcerative colitis].
Kamińska B; Landowski P; Gonkowski S; Szlagatys-Sidorkiewicz A; Majewski M; Dobosz M; Ismail H; Korzon M
Med Wieku Rozwoj; 2007; 11(2 Pt 1):117-22. PubMed ID: 17625279
[TBL] [Abstract][Full Text] [Related]
11. Vasoactive intestinal peptide concentrations and immunocytochemical studies in rectal biopsies from patients with inflammatory bowel disease.
O'Morain C; Bishop AE; McGregor GP; Levi AJ; Bloom SR; Polak JM; Peters TJ
Gut; 1984 Jan; 25(1):57-61. PubMed ID: 6360814
[TBL] [Abstract][Full Text] [Related]
12. Gastrointestinal dysfunction in mice with a targeted mutation in the gene encoding vasoactive intestinal polypeptide: a model for the study of intestinal ileus and Hirschsprung's disease.
Lelievre V; Favrais G; Abad C; Adle-Biassette H; Lu Y; Germano PM; Cheung-Lau G; Pisegna JR; Gressens P; Lawson G; Waschek JA
Peptides; 2007 Sep; 28(9):1688-99. PubMed ID: 17606312
[TBL] [Abstract][Full Text] [Related]
13. Regional differences in concentrations of regulatory peptides in human colon mucosal biopsy.
Calam J; Ghatei MA; Domin J; Adrian TE; Myszor M; Gupta S; Tait C; Bloom SR
Dig Dis Sci; 1989 Aug; 34(8):1193-8. PubMed ID: 2568900
[TBL] [Abstract][Full Text] [Related]
14. Vasoactive intestinal peptide stabilizes intestinal immune homeostasis through maintaining interleukin-10 expression in regulatory B cells.
Sun X; Guo C; Zhao F; Zhu J; Xu Y; Liu ZQ; Yang G; Zhang YY; Gu X; Xiao L; Liu Z; Yang PC
Theranostics; 2019; 9(10):2800-2811. PubMed ID: 31244924
[No Abstract] [Full Text] [Related]
15. [Changes of mast cells and gut hormones in rats with TNBS-induced ulcerative colitis].
Zhao P; Dong L; Luo JY; Guan HT; Ma H; Wang XQ
Nan Fang Yi Ke Da Xue Xue Bao; 2009 Jul; 29(7):1359-63. PubMed ID: 19620053
[TBL] [Abstract][Full Text] [Related]
16. Distribution of vasoactive intestinal polypeptide and substance P receptors in human colon and small intestine.
Korman LY; Sayadi H; Bass B; Moody TW; Harmon JW
Dig Dis Sci; 1989 Jul; 34(7):1100-8. PubMed ID: 2472937
[TBL] [Abstract][Full Text] [Related]
17. Colonic levels of vasoactive intestinal peptide decrease during infection and exogenous VIP protects epithelial mitochondria against the negative effects of IFNγ and TNFα induced during Citrobacter rodentium infection.
Maiti AK; Sharba S; Navabi N; Lindén SK
PLoS One; 2018; 13(9):e0204567. PubMed ID: 30252907
[TBL] [Abstract][Full Text] [Related]
18. Changes of colonic vasoactive intestinal peptide and cholinergic activity in rats with chemical colitis.
Kishimoto S; Kobayashi H; Shimizu S; Haruma K; Tamaru T; Kajiyama G; Miyoshi A
Dig Dis Sci; 1992 Nov; 37(11):1729-37. PubMed ID: 1425074
[TBL] [Abstract][Full Text] [Related]
19. Distribution and quantitation of gut neuropeptides in normal intestine and inflammatory bowel diseases.
Koch TR; Carney JA; Go VL
Dig Dis Sci; 1987 Apr; 32(4):369-76. PubMed ID: 2435473
[TBL] [Abstract][Full Text] [Related]
20. Vasoactive Intestinal Peptide Nanomedicine for the Management of Inflammatory Bowel Disease.
Jayawardena D; Anbazhagan AN; Guzman G; Dudeja PK; Onyuksel H
Mol Pharm; 2017 Nov; 14(11):3698-3708. PubMed ID: 28991483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
